Regulators are expected to make a decision in the third quarter of 2025 on Kerendia to treat patients with heart failure with ...

Global biosimilar regulatory harmonization will be needed to reduce development costs and improve patient access, despite ...

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

A growing number of women ? from A-list celebrities to your next-door neighbor ? are undergoing surgical explant procedures to combat a constellation of chronic, often severe symptoms that have come ...

As global markets grapple with ongoing trade uncertainties and recession fears, major indices like the S&P 500 and Dow Jones Industrial Average have seen consecutive weeks of negative returns. Amidst ...

Micro Bioreactor System Market is Segmented by Type (48 Parallel, 24 Parallel), by Application (Pharmaceutical, Sewage Treatment, Biochemical Engineering, Food ...